Dean Y. Li - Oct 1, 2024 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Director
Signature
/s/Jonathan Golightly, attorney-in-fact
Stock symbol
RXRX
Transactions as of
Oct 1, 2024
Transactions value $
$0
Form type
4
Date filed
10/4/2024, 06:29 PM
Previous filing
Jul 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Award $0 +1.93K +2.61% $0.00 75.7K Oct 1, 2024 Direct F1
holding RXRX Class A Common Stock 1.42M Oct 1, 2024 By Dean Li and Ruth Li Revocable Trust
holding RXRX Class A Common Stock 1.27M Oct 1, 2024 By Dean Y. Li GRAT
holding RXRX Class A Common Stock 421K Oct 1, 2024 By Dean Y. Li 2021 Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.